No Data
Astrazeneca (AZN.US) and Merck (MRK.US) jointly announced the positive top-line results of the KOMET phase 3 clinical trial.
Today, Astrazeneca (AZN.US) and Merck (MRK.US) jointly announced the positive top-line results of the phase 3 KOMET clinical trial.
Express News | Form 13f report shows that Deutsche Bank increased its shareholding in Apple, Broadcom, Meta Platforms, Tesla, and other stocks in the third quarter. They decreased their shareholding in Nvidia, Google C, Merck Pharmaceuticals, Bank of America, and other
10 Health Care Stocks With Whale Alerts In Today's Session
Merck & Co To Present At UBS Global Healthcare Conference; Webcast At 12:30 PM ET
Zentalis Pharmaceuticals Appoints Julie Eastland as CEO
Dow's 300-Point Fall Led By Losses In Shares Of Amgen, 3M